SkinBioTherapeutics PLC (SBTX) — Cash Flow Quality Index

Latest as of June 2025: -1.46x

SkinBioTherapeutics PLC (SBTX) has a Cash Flow Quality Index of -1.46x as of June 2025. Operating cash flow of GBX-494.84K is below net income of GBX337.85K, suggesting accrual-heavy earnings not yet converted to cash. Also explore SkinBioTherapeutics PLC total assets for the complete picture of this company's asset base.

Cash Flow Quality Index

-1.46x

Operating CF / Net Income

Operating Cash Flow

GBX-494.84K

GBX

Net Income

GBX337.85K

GBX

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for SkinBioTherapeutics PLC (None–None)

Year-by-year earnings quality comparison for SkinBioTherapeutics PLC. For live market cap and the full company financial profile, see how much is SkinBioTherapeutics PLC worth.

Year	Quality Index	Operating CF (GBX)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.